Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs

Archon Biosciences’ antibody cages change the structure of an antibody to control how a drug distributes in the body. The startup comes from the lab of David Baker, the University of Washington professor of biochemistry recently awarded the Nobel Prize in Chemistry for his work in computational protein design.

The post Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs appeared first on MedCity News.